These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16955304)

  • 1. [Mechanisms of specific immunotherapy].
    Bellinghausen I; Knop J; Saloga J
    Hautarzt; 2006 Oct; 57(10):855-9. PubMed ID: 16955304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-specific immunotherapy: an update on immunological mechanisms of action.
    Ciprandi G; Marseglia GL; Tosca MA
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):34-7. PubMed ID: 16700191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis.
    Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H
    Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interleukin 10 in the regulation of allergic immune responses.
    Bellinghausen I; Knop J; Saloga J
    Int Arch Allergy Immunol; 2001 Oct; 126(2):97-101. PubMed ID: 11729346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
    Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
    Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological mechanisms in allergen-specific immunotherapy: impact on future trends in type-1 allergy management].
    Ebner C
    Wien Med Wochenschr; 1999; 149(14-15):438-41. PubMed ID: 10584289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting dendritic cells in allergen immunotherapy.
    Novak N
    Immunol Allergy Clin North Am; 2006 May; 26(2):307-19, viii. PubMed ID: 16701146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current recommendations for the use of SCIT and SLIT].
    Lee H; Kleine-Tebbe J; Zuberbier T; Worm M
    Hautarzt; 2006 Oct; 57(10):860-6. PubMed ID: 16964477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
    Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
    Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement of skin test with IL-4 production and CD40L expression by T cells upon immunotherapy of subjects with systemic reactions to Hymenoptera stings.
    Urra JM; Cabrera CM; Alfaya T; Feo-Brito F
    Mol Immunol; 2016 Feb; 70():134-9. PubMed ID: 26774053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
    Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
    Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
    Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen immunotherapy for allergic rhinitis.
    Petalas K; Durham SR
    Rhinology; 2013 Jun; 51(2):99-110. PubMed ID: 23671890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update on current care guidelines: Allergen specific immunotherapy].
    Valovirta E; Korhonen K; Kuitunen M; Kukkonen-Harjula K; Lammintausta K; Pallasaho P; Ralli P; Savolainen J; Toskala E; Virtanen T
    Duodecim; 2012; 128(1):108-9. PubMed ID: 22312833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sublingual immunotherapy and Th1 adjuvant immunotherapy].
    Okamoto Y
    Arerugi; 2008 Jun; 57(6):685-91. PubMed ID: 18591899
    [No Abstract]   [Full Text] [Related]  

  • 20. Allergen immunotherapy.
    Frew AJ
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S306-13. PubMed ID: 20176266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.